Logo
Apparel & Fashion

Loading subcategories...

View More

Description

Lomoh-40 represents a trusted pharmaceutical solution specifically formulated for deep vein thrombosis prophylaxis and pulmonary embolism prevention in patients recovering from abdominal surgery. This anticoagulant injection delivers reliable therapeutic action through its consistent formulation, providing healthcare professionals with an effective tool to manage clotting risks during vulnerable post-operative periods. The product's stability and compatibility with standard medical protocols make it a practical choice for integration into existing treatment regimens, while its proven efficacy supports positive patient outcomes in surgical recovery scenarios.

Healthcare facilities across multiple specialties rely on Lomoh-40 for thromboprophylaxis in high-risk surgical patients. Hospitals utilize it extensively in abdominal surgery departments for procedures including colorectal operations, bariatric surgery, and oncological resections where prolonged recovery increases thrombosis pote...
Lomoh-40 represents a trusted pharmaceutical solution specifically formulated for deep vein thrombosis prophylaxis and pulmonary embolism prevention in patients recovering from abdominal surgery. This anticoagulant injection delivers reliable therapeutic action through its consistent formulation, providing healthcare professionals with an effective tool to manage clotting risks during vulnerable post-operative periods. The product's stability and compatibility with standard medical protocols make it a practical choice for integration into existing treatment regimens, while its proven efficacy supports positive patient outcomes in surgical recovery scenarios.

Healthcare facilities across multiple specialties rely on Lomoh-40 for thromboprophylaxis in high-risk surgical patients. Hospitals utilize it extensively in abdominal surgery departments for procedures including colorectal operations, bariatric surgery, and oncological resections where prolonged recovery increases thrombosis potential. Orthopedic centers incorporate it into post-operative care for joint replacement patients, while intensive care units administer it to bedridden patients requiring extended anticoagulation. Medical distributors supply this product to surgical centers, rehabilitation facilities, and long-term care institutions, ensuring broad availability for preventive care across the healthcare continuum.

Medical distributors and healthcare providers choose Lomoh-40 for its demonstrated reliability and consistent quality that builds trust in clinical settings. The product's long shelf life minimizes inventory waste and supports efficient supply chain management, while its proven performance record reduces clinical uncertainty. For healthcare facilities, it offers a dependable solution that integrates seamlessly into established protocols, while distributors benefit from steady demand and reliable reorder patterns from satisfied institutional clients who value consistent therapeutic outcomes.

Key Features:
- Specifically formulated for deep vein thrombosis prophylaxis
- Prevents pulmonary embolism following abdominal surgery
- Extended shelf life for inventory management efficiency
- Consistent pharmaceutical formulation and quality
- Reliable therapeutic action in post-operative care

Benefits:
- Reduces thrombosis risks in surgical recovery patients
- Supports positive patient outcomes through proven efficacy
- Minimizes inventory waste with extended product stability
- Builds trust through consistent quality and performance
- Integrates easily into existing medical treatment protocols

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Lomoh-40 is essential in hospital surgical units for patients undergoing major abdominal procedures like colorectal, bariatric, and oncological surgeries. Its consistent anticoagulant action helps prevent dangerous blood clots during the critical post-operative recovery phase, making it a trusted choice for surgeons and physicians in operating rooms and surgical wards. This injection also plays a vital role in orthopedic settings, particularly following hip and knee replacement surgeries where patient immobility significantly increases thrombosis risks. Medical distributors supply Lomoh-40 to rehabilitation centers, nursing facilities, and outpatient clinics, ensuring comprehensive thromboprophylaxis coverage across various healthcare environments and patient recovery stages. - Administered to abdominal surgery patients for deep vein thrombosis prevention - Used in post-operative protocols for hip and knee replacement surgeries - Essential medication for immobilized patients in intensive care units - Supplied to rehabilitation facilities for extended prophylaxis needs - Distributed to surgical centers and outpatient clinics for comprehensive care

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
TruBasic
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Lomoh 40 Anticoagulant Injection For Deep Vein Thrombosis Prophylaxis

Lomoh-40 anticoagulant injection prevents deep vein thrombosis and pulmonary embolism post-abdominal surgery, offering reliable efficacy, long shelf life, and consistent quality for medical distributors and healthcare providers.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier